BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35239225)

  • 1. Gene fusions in gastrointestinal tract cancers.
    Rahi H; Olave MC; Fritchie KJ; Greipp PT; Halling KC; Kipp BR; Graham RP
    Genes Chromosomes Cancer; 2022 May; 61(5):285-297. PubMed ID: 35239225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization.
    Krystel-Whittemore M; Taylor MS; Rivera M; Lennerz JK; Le LP; Dias-Santagata D; Iafrate AJ; Deshpande V; Chebib I; Nielsen GP; Wu CL; Nardi V
    Hum Pathol; 2019 Nov; 93():65-73. PubMed ID: 31430493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NTRK Fusions: A new way of treatment for gastro-intestinal tumor?].
    Ouali K; Pellat A; Cohen R; Svrcek M; Penault-Llorca F; André T
    Bull Cancer; 2020 Apr; 107(4):447-457. PubMed ID: 32067719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.
    Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T
    Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.
    Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J
    J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts.
    Pižem J; Šekoranja D; Zupan A; Boštjančič E; Matjašič A; Mavčič B; Contreras JA; Gazič B; Martinčič D; Snoj Ž; Limpel Novak KA; Salapura V
    Am J Surg Pathol; 2020 Dec; 44(12):1623-1634. PubMed ID: 32991339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and clinical utility of a pan-solid tumor targeted RNA fusion panel: A single center experience.
    Hindi I; Shen G; Tan Q; Cotzia P; Snuderl M; Feng X; Jour G
    Exp Mol Pathol; 2020 Jun; 114():104403. PubMed ID: 32061944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.
    Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O
    Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
    Ali SM; Hensing T; Schrock AB; Allen J; Sanford E; Gowen K; Kulkarni A; He J; Suh JH; Lipson D; Elvin JA; Yelensky R; Chalmers Z; Chmielecki J; Peled N; Klempner SJ; Firozvi K; Frampton GM; Molina JR; Menon S; Brahmer JR; MacMahon H; Nowak J; Ou SH; Zauderer M; Ladanyi M; Zakowski M; Fischbach N; Ross JS; Stephens PJ; Miller VA; Wakelee H; Ganesan S; Salgia R
    Oncologist; 2016 Jun; 21(6):762-70. PubMed ID: 27245569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Fusions in Ocular Adnexal Tumors.
    Milman T; Ida CM; Zhang PJL; Eagle RC
    Am J Ophthalmol; 2021 Jan; 221():211-225. PubMed ID: 32800827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiomatoid fibrous histiocytoma: comparison of fluorescence in situ hybridization and reverse transcription polymerase chain reaction as adjunct diagnostic modalities.
    Thway K; Gonzalez D; Wren D; Dainton M; Swansbury J; Fisher C
    Ann Diagn Pathol; 2015 Jun; 19(3):137-42. PubMed ID: 25804255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
    Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
    J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic EWSR1-FLI1 fusions in Ewing sarcoma: potential pitfalls in the diagnostic use of fluorescence in situ hybridization probes.
    Newby R; Rowe D; Paterson L; Farquharson MA; MacDuff E; Coupe A; Hale J; Dildey P; Bown N
    Cancer Genet Cytogenet; 2010 Jul; 200(1):60-4. PubMed ID: 20513536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location.
    Kao YC; Sung YS; Zhang L; Chen CL; Vaiyapuri S; Rosenblum MK; Antonescu CR
    Am J Surg Pathol; 2017 Apr; 41(4):482-490. PubMed ID: 28009602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of RNA-Based Next-Generation Sequencing Assays for the Detection of NTRK Gene Fusions.
    Park HJ; Baek I; Cheang G; Solomon JP; Song W
    J Mol Diagn; 2021 Nov; 23(11):1443-1451. PubMed ID: 34756276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance Analysis of ALK Gene Fusion Detection Methods in Patients with Non-Small-Cell Lung Cancer from Chile, Brazil, and Peru.
    Sepúlveda-Hermosilla G; Freire M; Blanco A; Cáceres J; Lizana R; Ramos L; Assar Cuevas R; Ampuero D; Aren O; Chernilo S; Spencer ML; Bernal G; Flores J; Rasse G; Sánchez C; Marcelain K; Rivas S; Branco GP; Galli de Amorim M; Nunes DN; Dias-Neto E; Freitas HC; Fernández C; ; Pérez P; Armisén R
    J Mol Diagn; 2021 Sep; 23(9):1127-1137. PubMed ID: 34186175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
    Kirchner M; Glade J; Lehmann U; Merkelbach-Bruse S; Hummel M; Lehmann A; Trautmann M; Kumbrink J; Jung A; Dietmaier W; Endris V; Kazdal D; Ploeger C; Evert M; Horst D; Kreipe H; Kirchner T; Wardelmann E; Büttner R; Weichert W; Dietel M; Schirmacher P; Stenzinger A; Pfarr N
    Genes Chromosomes Cancer; 2020 Aug; 59(8):445-453. PubMed ID: 32319699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.
    Hsiao SJ; Zehir A; Sireci AN; Aisner DL
    J Mol Diagn; 2019 Jul; 21(4):553-571. PubMed ID: 31075511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.